Extracellular Domain of the Transforming Growth Factor-β Receptor Negatively Regulates Ligand-independent Receptor Activation
Open Access
- 1 October 1999
- journal article
- Published by Elsevier BV
- Vol. 274 (41), 29220-29227
- https://doi.org/10.1074/jbc.274.41.29220
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibitionInternational Journal of Cancer, 1996
- Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptorsCurrent Opinion in Cell Biology, 1996
- Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- The TGF-β family and its composite receptorsTrends in Cell Biology, 1994
- The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.Genes & Development, 1994
- Receptors for the TGF-β superfamily: multiple polypeptides and serine/threonine kinasesTrends in Cell Biology, 1993
- Transforming Growth Factor-β: Latent Forms, Binding Proteins and ReceptorsGrowth Factors, 1993
- TGFβ signals through a heteromeric protein kinase receptor complexCell, 1992
- Receptors for the TGF-β familyCell, 1992